Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Current Liabilities

    Back to Balance Sheet
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Current Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Current Liabilities -----

What is the latest Current Liabilities ratio of GLENMARK PHARMACEUTICALS ?

The latest Current Liabilities ratio of GLENMARK PHARMACEUTICALS is - based on Mar2026 Consolidated results.
Year Current Liabilities
Mar2026-
Mar2025-
Mar2024-
Mar2023-
Mar2022-

How is Current Liabilities of GLENMARK PHARMACEUTICALS Trending?

Years Current Liabilities % Change
Mar2026 -
0
Mar2025 -
0
Mar2024 -
0
Mar2023 -
0
Mar2022 - -

Compare Current Liabilities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹69,308.3 Cr 5% 11.7% 24.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹455,994.0 Cr NA -3.9% 17.3% Stock Analytics
DIVIS LABORATORIES ₹240,249.0 Cr 5% 21.5% 44.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹191,135.0 Cr -2.1% -0.2% 34.3% Stock Analytics
CIPLA ₹114,708.0 Cr -2% -2.5% -8.1% Stock Analytics
DR REDDYS LABORATORIES ₹98,074.9 Cr 0.4% 4.5% -4.4% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

5%

11.7%

24.6%

SENSEX

-0.8%

0.2%

-6%


You may also like the below Video Courses